Predicting outcomes in hyperthyroid cats treated with radioiodine

被引:6
|
作者
Peterson, Mark E. [1 ,2 ]
Rishniw, Mark [2 ,3 ]
机构
[1] Anim Endocrine Clin, 220 Manhattan Ave, New York, NY 10025 USA
[2] Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA
[3] Vet Informat Network, Davis, CA USA
关键词
I-131; feline; hypothyroidism; radioactive iodine; thyroid gland; treatment failure; THYROID-STIMULATING HORMONE; TOXIC NODULAR GOITER; RADIOACTIVE IODINE; LOGISTIC-REGRESSION; FELINE HYPERTHYROIDISM; PROGNOSTIC-FACTORS; THERAPY; HYPOTHYROIDISM; PERTECHNETATE; I-131;
D O I
10.1111/jvim.16319
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Background Radioiodine (I-131) is the treatment of choice for cats with hyperthyroidism. After I-131, however, euthyroidism is not always achieved, with 5% to 10% of cats remaining persistently hyperthyroid and 20% to 50% developing iatrogenic hypothyroidism. Objectives To identify pretreatment factors that may help predict persistent hyperthyroidism and iatrogenic hypothyroidism after treatment of cats using a novel I-131 dosing algorithm. Animals One thousand and four hundred hyperthyroid cats treated with I-131. Methods Prospective, before-and-after study. Pretreatment predictors (clinical, laboratory, scintigraphic, I-131 dose, I-131 uptake measurements) of treatment failure or iatrogenic hypothyroidism were identified by multivariable logistic regression analysis. Results Cats that developed iatrogenic hypothyroidism were more likely to be older (odds ratio [OR] = 1.10; 95% confidence interval [CI], 1.04-1.17; P = .001), female (OR = 2.04; 95% CI, 1.54-2.70; P < .001), have detectable serum thyroid-stimulating hormone (TSH) concentrations (OR = 4.19; 95% CI, 2.0-8.81; P < .001), have bilateral thyroid nodules (OR = 1.57; 95% CI, 1.19-2.08; P < .001), have homogeneous, bilateral distribution of Tc-99m-pertechnetate uptake (OR = 2.93; 95% CI, 2.05-4.19; P < .001), have milder severity score (OR = 0.62; 95% CI, 0.49-0.79; P < .001), and have higher I-131 uptake (OR = 2.40; 95% CI, 1.75-3.28; P < .001). In contrast, cats remaining persistently hyperthyroid were more likely to be younger (OR = 0.81; 95% CI, 0.72-0.92; P < .001), have higher severity score (OR = 1.87; 95% CI, 1.51-2.31; P < .001), and have lower I-131 uptake (OR = 3.50; 95% CI, 1.8-6.80; P < .001). Conclusions and Clinical Importance Age, sex, serum TSH concentration, bilateral and homogeneous Tc-99m-pertechnetate uptake on scintigraphy, severity score, and percent I-131 uptake are all factors that might help predict outcome of I-131 treatment in hyperthyroid cats. Cats with persistent hyperthyroidism had many predictive factors that directly contrasted those of cats that developed I-131-induced hypothyroidism.
引用
收藏
页码:49 / 58
页数:10
相关论文
共 50 条
  • [1] Radioiodine treatment of hyperthyroidism in cats: results of 165 cats treated by an individualised dosing algorithm in Spain
    Xifra, Pilar
    Serrano, Sara, I
    Peterson, Mark E.
    JOURNAL OF FELINE MEDICINE AND SURGERY, 2022, 24 (08) : E258 - E268
  • [2] Assessment of treatment outcomes in hyperthyroid cats treated with an orally administered fixed dose of radioiodine
    Yu, Lucia
    Lacorcia, Lauren
    Finch, Sue
    Johnstone, Thurid
    JOURNAL OF FELINE MEDICINE AND SURGERY, 2020, 22 (08) : 744 - 752
  • [3] Effect of radioiodine treatment on muscle mass in hyperthyroid cats
    Xifra, Pilar
    Serrano, Sara, I
    Peterson, Mark E.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2022, 36 (06) : 1931 - 1941
  • [4] Assessment of symmetric dimethylarginine as a biomarker of renal function in hyperthyroid cats treated with radioiodine
    Buresova, Eva
    Stock, Emmelie
    Paepe, Dominique
    Stammeleer, Lisa
    Vandermeulen, Eva
    Smets, Pascale
    Duchateau, Luc
    Lefebvre, Herve P.
    Daminet, Sylvie
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2019, 33 (02) : 516 - 522
  • [5] Effect of thyroid volume on radioiodine therapy outcome in hyperthyroid cats
    Volckaert, Veerle
    Vandermeulen, Eva
    Dobbeleir, Andre
    Duchateau, Luc
    Saunders, Jimmy H.
    Peremans, Kathelijne
    JOURNAL OF FELINE MEDICINE AND SURGERY, 2016, 18 (02) : 144 - 149
  • [6] A dosing algorithm for individualized radioiodine treatment of cats with hyperthyroidism
    Peterson, Mark E.
    Rishniw, Mark
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2021, 35 (05) : 2140 - 2151
  • [7] Prevalence of iatrogenic hypothyroidism in hyperthyroid cats treated with radioiodine using an individualised scoring system
    Fernandez, Yordan
    Puig, Jordi
    Powell, Roger
    Seth, Mayank
    JOURNAL OF FELINE MEDICINE AND SURGERY, 2019, 21 (12) : 1149 - 1156
  • [8] Blood pressure in hyperthyroid cats before and after radioiodine treatment
    Stammeleer, Lisa
    Xifra, Pilar
    Serrano, Sara I.
    Rishniw, Mark
    Daminet, Sylvie
    Peterson, Mark E.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2024, 38 (03) : 1359 - 1369
  • [9] Predictors of response to radioiodine therapy in hyperthyroid cats
    Chun, R
    Garrett, LD
    Sargeant, J
    Sherman, A
    Hoskinson, JJ
    VETERINARY RADIOLOGY & ULTRASOUND, 2002, 43 (06) : 587 - 591
  • [10] Hyperthyroid cats that develop azotemia following successful radioiodine treatment have shorter survival times compared to cats that remain nonazotemic
    Peterson, Mark E.
    Carmody, Stephanie
    Rishniw, Mark
    JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2025, 263 (04): : 454 - 459